The assay of indomethacin in the presence of its hydrolytic degradation products
Krasowska, H.; Krówczyński, L.; Bogdanik, Z.
Polish Journal of Pharmacology and Pharmacy 25(4): 417-421
1973
ISSN/ISBN: 0301-0244 PMID: 4774252 Document Number: 59262
Document emailed within 1 workday
Related Documents
Mohammad, M.A.-A.; Zawilla, N.H.; El-Anwar, F.M.; Aly, S.M.E.-m. 2007: Column and thin-layer chromatographic methods for the simultaneous determination of acediasulfone in the presence of cinchocaine, and cefuroxime in the presence of its hydrolytic degradation products Journal - Association of Official Analytical Chemists 90(2): 405-413Mehta, T.N.; Patel, A.K.; Kulkarni, G.M.; Suubbaiah, G. 2005: Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method Journal - Association of Official Analytical Chemists 88(4): 1142-1147
Sen, D.K.; Sarin, G.S. 1981: Assay of fibrin degradation products in human aqueous humour Indian Journal of Ophthalmology 29(2): 87-89
Sabino, M.A.; Morales, D.; Ronca, G.; Feijoo, J.é L. 2003: Study of the hydrolytic degradation of a biodegradable copolymer Acta Cientifica Venezolana 54(1): 18-27
Li, W.-M.; Bao, Y.-Y.; Zhou, Q.-X. 2012: Degradation pathways and main degradation products of tetracycline antibiotics: research progress Ying Yong Sheng Tai Xue Bao 23(8): 2300-2308
Huang, Z.; Ma, L.; Liu, W.; Cheng, Y. 1999: Isotachophoresis analysis of hydrolytic products of DFP catalyzed by DFPase in porcine liver Se Pu 17(2): 196-198
Anschel, J.; Mollica, J.A.; Lin, K.S. 1972: Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions Bulletin of the Parenteral Drug Association 26(6): 271-289
Adegoke, O.Aremu.; Idowu, O.Sunday.; Olaniyi, A.Akinyemi. 2006: Novel colorimetric assay of indomethacin using 4-carboxyl-2,6-dinitrobenzene diazonium ion Acta Pharmaceutica 56(2): 189-202
Kuroso, K.; Fujimaki, M. 1989: Fibrin/fibrinogen degradation products (FDP) Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 892-895
Tada, H.; Kuboki, K.; Isogai, S. 1998: Urinary fibronectin degradation products Nihon Rinsho. Japanese Journal of Clinical Medicine 56(Suppl 3): 354-359
Fujimaki, M.; Ikematsu, S.; Kato, M. 1973: Fibrinogen and fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 21(1): 31-36
Facchini, G.; Filippi, G.; Cantoni, R.; Nannetti, M. 1987: Quantitative determination of feprazone in the presence of possible degradation by HPLC Bollettino Chimico Farmaceutico 126(6): 244-245
Bettini, V.; Gamba, G.; Guido, A.; Legrenzi, E.; Mayellaro, F. 1983: Effect of a bioflavinoid (4-methylesculetin) on the response of calf hepatic arteries to serotonin in the presence of indomethacin Bollettino della Societa Italiana di Biologia Sperimentale 59(9): 1231-1235
Galvan, L.; Strong, J.E.; Crooke, S.T. 1979: Use of PM-2 DNA degradation as a pharmacokinetic assay for bleomycin Cancer Research 39(10): 3948-3951
Jörres, A.; Bender, T.O.; Witowski, J. 2000: Glucose degradation products and the peritoneal mesothelium Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 5): S19-S22
Surviladze, Z.G.; Dudkin, S.M. 1979: Steady state kinetics of DNA degradation with pancreatic deoxyribonuclease a in the presence of Mg2+ Molekuliarnaia Biologiia 13(1): 205-215
Piecuch, T.; Muzała-Bogdan, B. 1982: Serum fibrinogen degradation products in various surgical conditions Wiadomosci Lekarskie 35(7-8): 473-478
Witowski, J.; Jörres, A. 2000: Glucose degradation products: relationship with cell damage Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S31-S36
Wieslander, A.; Forsbäck, G.; Svensson, E.; Lindén, T. 1996: Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 12: 57-60
Khristov, V.; Apostolov, P.; Stamenova, T. 1979: Fibrin degradation products in the urine in diabetic nephropathy Vutreshni Bolesti 18(4): 32-36